Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Hammerson, Marshalls, Warpaint London

(Sharecast News) - Citi upgraded Hammerson to 'buy' from 'neutral' on Wednesday and lifted the price target to 43.0p from 26.0p, saying it was entering a "new positive up cycle". The bank said that having sold its low-yielding value retail business, Hammerson can "finally look forward to growth" at a time when shopping centre asset values and rents will likely grow from a low-base as a new positive real estate cycle emerges.

The analysts increased their price target and revised their estimates to reflect higher net asset value and earnings per share, and "with around 48% expected total return we upgrade to buy".

Citi also noted the shares trade at a significant discount versus past growth cycles.

"Applying historical growth cycle multiples to our estimates suggests a valuation corridor of 43.6p to 76.1p, offering upside potential to support our buy rating," it said

RBC Capital Markets initiated coverage of Marshalls on Wednesday with a 'sector perform' rating and 370p price target.

It noted that Marshalls outperformed the FTSE 250 by 10x and traded at 18x average price-to-earnings, a premium of around 40% to peers from 2013 to 2021, and said earnings per share and return on capital employed increased by around 3x.

"Enter Marley, a transformational deal which coincided with a cyclical downturn in 2022. 2024e adjusted EPS is over 50% below 'normalised' levels," it said. Marshalls bought pitched roof tile specialist Marley Group for £535.0m.

"Prior CEO Martyn Coffey departed and now we await a new midterm strategy. We think a pathway back towards pre-Marley ROCE and above market earnings growth is needed to justify prior valuation levels. Marshalls' premium remains in-tact despite lower adjusted EPS growth and ROCE."

Analysts at Berenberg hiked their target price on cosmetics group Warpaint London from 580.0p to 680.0p on Wednesday after the company delivered "significant" end-market outperformance and margin expansion in its interim report card.

Berenberg believes the strength of Warpaint's gross margin was the main feature of its H124 results, which it expects to drive upgrades to consensus.

"We see a considerable runway for further revenue growth and anticipate incremental margin expansion beyond the 334 basis point year-on-year that it delivered in H124," said the German bank.

"Our view of the sustainability of Warpaint's revenue growth is predicated on the further expansion of its store presence within its existing customer base - in which, we think Warpaint is significantly underpenetrated."

Berenberg, which reiterated its 'buy' rating on the stock, added that Warpaint currently trades on a 21.7x 12-month forward price-to-earnings ratio - one-half standard deviation above its long-run historical average.

Share this article

Related Sharecast Articles

Europe close: Stocks inch lower after choppy session
(Sharecast News) - Thursday saw choppy trading across European stock markets with the region's main benchmark finishing lower but moving within a narrow range, as investors focused on mixed economic data from the US and developments in the Middle East.
Director dealings: Next director offloads shares
(Sharecast News) - Next revealed on Thursday that executive director Jeremy Stakol and his wife Marcelle had disposed of 26,523 ordinary shares in the London-listed retailer.
FTSE 250 movers: Indivior tanks on profit warning; Auction Technology surges
(Sharecast News) - FTSE 250 (MCX) 20,723.35 -0.48%
London close: Stocks red as US inflation, jobless claims top forecasts
(Sharecast News) - London's stock markets ended Thursday in negative territory as investors weighed a higher-than-expected inflation and jobless claims readings out of the United States.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.